WHITE PAPER:
When you understand people and their names in context and in real time, you have an increased capability to preempt threats and fraud. Find out what you can do to help protect your business.
WHITE PAPER:
Due to the financial meltdown in the mortgage-backed securities industry, new compliance requirements will be implemented. Read this paper to find out how organizations can ensure compliance with stricter regulations and manage risk appropriately so the business does not slip into non-compliance resulting in negative publicity or punitive fines.
CASE STUDY:
Researchers found that by creating a dynamic IT environment- standardized, centralized, automated, and mobile-California can achieve a greener, more secure computing complex that improves productivity, delivering greater efficiency at a lower cost to taxpayers and the environment.
WHITE PAPER:
The white paper discusses what US organizations can do to prepare for International Financial Reporting Standards (IFRS), and focuses on what Oracle's Enterprise Performance Management solutions can do to help with top-end reporting.
WHITE PAPER:
There is a more positive scenario - a "win-win" - but it is one that will require new levels of accountability, tough decisions and hard work on the part of all stakeholders.
WHITE PAPER:
Provides a brief introduction to the July 2003 updated FCC regulations regarding fax and discusses tools to help companies fax responsibly.
WHITE PAPER:
The 11th book in our Straight Talk series helps executives understand the implications of IFRS and their role in addressing the associated changes. The publication also offers practical suggestions to help companies navigate through pressing issues and developing your own conversion road map.
CASE STUDY:
Learn how Kalypsis, a clinical stage pharmaceutical company, is leveraging Xerox DocuShare Enterprise Content Management to control content for regulatory operations and clinical trials.
CASE STUDY:
When GlaxoSmithKline was challenged with improving efficiency in modeling and simulation, their clinical development research team turned to Univa technology for faster methods of establishing and running models for a drug’s effects on the body.
